Prospects and advances in hormonal immunomodulatory therapy.
Modulation of the immune network through the hormonal system is an exciting emerging concept. It results from a decade of experimental research obtained on rodents. Unfortunately, the therapeutic response on NZB/NZW F1 mice with murine lupus or in adjuvant induced arthritis are not transferable to man. This new field opens new therapeutic perspectives with well known and relatively safe drugs (hormone agonists, antagonists or inhibitors of hormonal secretion). Today we lack controlled, randomized clinical studies, with long-term follow-up. We also need to identify the subgroup of patients who could benefit from hormonal immunomodulation (sex, basal hormonal status, menopausal status for women, disease activity).
Immuno-Rheumatology Department, Lapeyronie Hospital, Montpellier, France.
C
C
Jorgensen
J
J
Sany
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D001327:Autoimmune Diseases / Q000628:therapy*; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy / Q000639:trends*; D012216:Rheumatic Diseases / Q000628:therapy*
D000276:Adjuvants, Immunologic; D006728:Hormones